Log In Get Started
Press Releases July 27, 2026 04:01 PM

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Carlsmed Announces Participation in Key Upcoming Investor Conferences

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
CARL

Carlsmed, Inc., a medical technology company specializing in AI-enabled personalized spine surgery solutions, announced its management team's participation in two upcoming virtual investor conferences in August 2026, including the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference and the Bank of America SMID Cap Virtual Conference. These events will feature one-on-one meetings and a fireside chat, providing opportunities to engage with investors and discuss company developments.

Carlsmed, Inc. To Participate in Upcoming Investor Conferences
CARL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Carlsmed is focusing on AI-enabled personalized spine surgery technology, impacting the medical technology and healthcare sectors.
  • Management will participate in prominent virtual investor conferences, enhancing investor relations and visibility.
  • The company offers live and archived webcasts to facilitate investor engagement and transparency.

CARLSBAD, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions today announced that management will participate in the following investor conferences:

  • 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference. The Company will host one-on-one meetings on Monday, August 10, 2026.
  • Bank of America SMID Cap Virtual Conference. Fireside chat on Wednesday, August 12, 2026, at 11:00 AM ET. A live webcast will be available to registered participants. Investors interested in participating in virtual one-on-one meetings should contact their Bank of America representative.

A live and archived webcast of the Bank of America SMID Cap Virtual Conference will be available in the Events & Presentations section of the company’s investor website at investors.carlsmed.com.

About Carlsmed

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
[email protected]

Media
[email protected]
  


Risks

  • Market reception to the company's technology and growth potential remains uncertain, influencing investor sentiment in the medtech sector.
  • Virtual conference participation may have limited impact if broader market or sector conditions are unfavorable.
  • Competitive pressures in the medical technology industry could affect Carlsmed's ability to capitalize on investor interest.

More from Press Releases

Rocket Lab Successfully Launches 16th Electron Mission Of The Year, Solidifies Status as World’s Leading Small Launch Provider Sep 11, 2026 Tenable Holdings, Inc. Announces Pricing of Upsized $725.0 Million Offering of Convertible Senior Notes Sep 10, 2026 Switch to Verizon and get the new iPhone 18 Pro now. No trade-in needed. And get the latest iPhone every year. Sep 10, 2026 North American Construction Group Announces the Appointment of Brad Rogers as President, Chief Executive Officer and Director Sep 10, 2026 Heartland Express Inc. Earns 21st Quest for Quality Award Sep 10, 2026